carbidopa 25 mg levodopa 250 mg
INDICATIONS AND USAGE Carbidopa and levodopa tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. Carbidopa allows patients treated for Parkinson's disease to use much lower doses of levodopa. Some patients who responded poorly to levodopa have improved on carbidopa and levodopa tablets. This is most likely due to decreased peripheral decarboxylation of levodopa caused by administration of carbidopa rather than by a primary effect of carbidopa on the nervous system. Carbidopa has not been shown to enhance the intrinsic efficacy of levodopa. Carbidopa may also reduce nausea and vomiting and permit more rapid titration of levodopa.
aurobindo pharma limited
ROUND BLUE CA 25 LT 250
Related Pills
carbidopa 25 mg levodopa 100 mg
aurobindo pharma limited
carbidopa 10 mg levodopa 100 mg
aurobindo pharma limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
CARBIDOPA AND LEVODOPA Tablets USP, 25 mg/100 mg are yellow to light yellow color, round shaped, uncoated tablets debossed with “CA 25” on one side and “LT 100” on the other side. They are supplied as follows: Bottles of 100 NDC 59651-457-01 Bottles of 500 NDC 59651-457-05 Bottles of 1000 NDC 59651-457-99
CARBIDOPA AND LEVODOPA Tablets USP, 10 mg/100 mg are blue to light blue color, round shaped, uncoated tablets debossed with “CA 10” on one side and “LT 100” on the other side. They are supplied as follows: Bottles of 100 NDC 59651-456-01 Bottles of 500 NDC 59651-456-05
CARBIDOPA AND LEVODOPA Tablets USP, 25 mg/250 mg are blue to light blue color, round shaped, uncoated tablets debossed with “CA 25” on one side and “LT 250” on the other side. They are supplied as follows: Bottles of 100 NDC 59651-458-01 Bottles of 500 NDC 59651-458-05 Bottles of 1000 NDC 59651-458-99 Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Store in a tightly closed container, protected from light and moisture. Dispense in a tightly closed, light-resistant container. Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 032, India Issued: July 2022
More pills like ROUND CA 25 LT 250